Information  X 
Enter a valid email address

Medgenics Inc (MEDG)

  Print   

Friday 15 November, 2013

Medgenics Inc

Directors Dealings

RNS Number : 1777T
Medgenics Inc
15 November 2013
 



 

 

Press Release

15 November 2013

 

 

Directors Dealings

 

Medgenics, Inc. (AIM: MEDU, MEDG and NYSE MKT: MDGN), the developer of BiopumpTM, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that, on 11 November 2013 it was informed by Dr. Sol Barer, Chairman of the Board of Directors of the Company, that he purchased on the open market 25,000 shares of common stock on that day at an average price of $6.8049 per share.

 

Following this purchase, Dr. Barer now owns 72,000 shares of common stock, which represents approximately 0.4 percent of the total issued shares of common stock.  Dr. Barer, directly or through trusts for the benefit of Dr. Barer and his family, also has the right to purchase up to 1,315,000 shares of common stock pursuant to options previously granted (in aggregate Dr. Barer's shares of common stock and options represent 1,387,000 shares of common stock which represent approximately 7.5 percent of the Company's total issued shares of common stock).

 

This announcement is being made pursuant to the London Stock Exchange's AIM Rules for Companies admitted to trading on the AIM market.

 

 

About Medgenics

 

Medgenics is developing and commercializing Biopump™, a proprietary tissue-based platform technology for the sustained production and delivery of therapeutic proteins using the patient's own tissue for the treatment of a range of chronic diseases including anemia, hepatitis, among others.  For more information, please visit www.medgenics.com

  



Contacts:

 

Medgenics, Inc.

John Leaman, CFO

[email protected]

 


Abchurch Communications

Joanne Shears / Jamie Hooper / Harriet Rae

[email protected]

 

+44 207 398 7718

 

Oriel Securities (NOMAD & Joint Broker)

Jonathan Senior / Giles Balleny

 

+44 207 710 7617 

 

SVS Securities plc (Joint Broker)

Alex Brearley

 

+44 203 700 0100

 

 

 

-Ends-


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUVUOROBAAAAA

a d v e r t i s e m e n t